» Articles » PMID: 33004514

Extensive Heterogeneity in Somatic Mutation and Selection in the Human Bladder

Abstract

The extent of somatic mutation and clonal selection in the human bladder remains unknown. We sequenced 2097 bladder microbiopsies from 20 individuals using targeted ( = 1914 microbiopsies), whole-exome ( = 655), and whole-genome ( = 88) sequencing. We found widespread positive selection in 17 genes. Chromatin remodeling genes were frequently mutated, whereas mutations were absent in several major bladder cancer genes. There was extensive interindividual variation in selection, with different driver genes dominating the clonal landscape across individuals. Mutational signatures were heterogeneous across clones and individuals, which suggests differential exposure to mutagens in the urine. Evidence of APOBEC mutagenesis was found in 22% of the microbiopsies. Sequencing multiple microbiopsies from five patients with bladder cancer enabled comparisons with cancer-free individuals and across histological features. This study reveals a rich landscape of mutational processes and selection in normal urothelium with large heterogeneity across clones and individuals.

Citing Articles

Cancer-independent somatic mutation of the wild-type NF1 allele in normal tissues in neurofibromatosis type 1.

Oliver T, Lawson A, Lee-Six H, Tollit A, Jung H, Hooks Y Nat Genet. 2025; 57(3):515-521.

PMID: 40000831 PMC: 11906363. DOI: 10.1038/s41588-025-02097-2.


ImmuneLENS characterizes systemic immune dysregulation in aging and cancer.

Bentham R, Jones T, Black J, Martinez-Ruiz C, Dietzen M, Litovchenko M Nat Genet. 2025; 57(3):694-705.

PMID: 39966644 PMC: 11906351. DOI: 10.1038/s41588-025-02086-5.


Variation in cancer risk between organs can not be explained by the degree of somatic clonal expansion.

Zhang D, Zhang A, He X, Deng S Adv Biotechnol (Singap). 2025; 2(2):18.

PMID: 39883325 PMC: 11740857. DOI: 10.1007/s44307-024-00025-9.


Single-cell DNA sequencing reveals pervasive positive selection throughout preleukemic evolution.

Poon G, Vedi A, Sanders M, Laurenti E, Valk P, Blundell J Cell Genom. 2025; 5(2):100744.

PMID: 39842433 PMC: 11872528. DOI: 10.1016/j.xgen.2024.100744.


Loss of Kmt2c or Kmt2d primes urothelium for tumorigenesis and redistributes KMT2A-menin to bivalent promoters.

Wang N, Pachai M, Li D, Lee C, Warda S, Khudoynazarova M Nat Genet. 2025; 57(1):165-179.

PMID: 39806204 PMC: 11735410. DOI: 10.1038/s41588-024-02015-y.